The Latest Cardiac and Vascular News
Phase 1 trial evaluated the pharmacokinetics and safety of HBI-3000 when dosed with thestrong CYP2D6 inhibitor, paroxetine SAN DIEGO, May 17, 2022 /PRNewswire/ — HUYABIO International, the leader in accelerating global development of China’s pharmaceutical innovations, today announced the successful completion of a Phase 1 drug-drug interaction clinical trial of HBI-3000, a novel drug for cardioversion […]
Company to focus on improving the quality of care for all cardiovascular patients in the U.S. ALISO VIEJO, Calif.–(BUSINESS WIRE)–On the heels of its landmark valvular heart disease (VHD) prevalence abstract published in Journal of the American College of Cardiology (JACC), egnite, Inc. today announced that it has expanded the company’s focus […]
Pulse Technologies’ HSR™ electrode surface treatment is now part of Cardionomic’s Cardiac Pulmonary Nerve Stimulation (CPNS) System for treating heart failure. QUAKERTOWN, Pa., May 16, 2022 /PRNewswire/ — Pulse Technologies Inc. has announced that its proprietary Hierarchical Surface Restructuring (HSR™) technology is being utilized as part of Cardionomic’s Cardiac Pulmonary Nerve Stimulation […]
CARLSBAD, Calif., May 13, 2022 (GLOBE NEWSWIRE) — Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced successful completion of patient enrollment in the company’s AcQForce™ Flutter Investigational Device Exemption (IDE) clinical trial which enrolled 110 patients at […]
Company Is Committed to Innovation for Patients Living With Heart Failure MARLTON, N.J., May 10, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is announcing today the first implants of its newly launched Optimizer® Smart Mini, […]
– Aiming to Realize 3 Zeros: “Zero Cerebrovascular and Cardiovascular Events,” “Zero Aggravation of Respiratory Diseases” and “Zero Restrictions on Daily Activities Due to Chronic Pain” – KYOTO, Japan, May 10, 2022 /PRNewswire/ — In March 2022, OMRON Group announced a new long-term vision, “Shaping the Future 2030” (hereafter referred to as SF2030). In its commitment […]
PARIS, May 09, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat hypertension and heart failure, announces today that it has recruited all planned patients in its phase III pivotal study FRESH, […]
Global heart health leader urges Americans to monitor blood pressure regularly and take action to manage hypertension among increased health risks associated with COVID-19 pandemic HOFFMAN ESTATES, Ill., May 5, 2022 /PRNewswire/ — Global heart health leader,, today issued a national health alert warning of increased heart health risks emerging from the […]
Point-of-care cardiac screening solution honored at sixth annual awards program for improving detection of heart disease OAKLAND, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Eko, a digital health company advancing heart and lung disease detection, today announced that, for the second consecutive year, it has won the “Best Use of Artificial […]
ECGenius Sets a New Standard for ECG Signal Detection, Interpretation and Therapy Support COPENHAGEN, Denmark , May 4, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the FDA 510(k) clearance of the ECGenius EP Recording System. ECGenius, the […]
